OUR MISSION is to serve pharmaceutical clients that provide cures and treatments for gastro-entrological diseases including: gallstones, PBC, PSC and NASH.
We are pleased to announce that on May 2nd ICE Group completed the purchase of the Iwaki Ursodeoxycholic Acid (“UDCA”) manufacturing site from Mitsubishi API Corporation. This transaction represents the end of an acquisition process that started in October 2021.
Tokyo Tanabe was the originally developer of…
We are pleased to announce that on December 15th ICE Group completed the acquisition of ABC Farmaceutici S.p.A (“ABC”). ABC is a pharmaceutical company based in Ivrea, Italy. Founded in 1925, the company is dedicated to the research, development,…
In May 2019 the cogenerator project was ended and realized. Project was supported by POS FESR PIEMONTE 2014-2020.
The principal goals of the project were:
- reduction of energy costs derived from the large use of electricity and steam in production processes.
- the company's conversion…
ABOUT ICE GROUP
ICE Group is a globally integrated business that produces ingredients for the pharmaceutical industry. Our main product is Ursodeoxycholic Acid (UDCA), a key ingredient in drugs treating liver conditions.
Founded more than sixty years ago, ICE Group is a global leader in bile-related products, with a network of specialist facilities around the world.
ICE’s first plant was opened in Reggio Emilia, Italy (production of Cholic Acid and bile acids derivatives)
BBA Industria Quimica (former Opoterapica) founded in Paranà, Brazil (collection of ox bile and its transformation in raw Cholic Acid)
Acquisition of RPT Texas, USA (collection and concentration of ox bile)
Opening of Arennis in Argentina (collection and concentration of ox bile)
Opening of Walfed Pty in Australia (collection and concentration of ox bile)
Acquisition of PCA, a major manufacturer of UDCA and derivative in Italy
Opening of PBP in Paraguay (collection and concentration of ox bile)
Opening of CVF in Uruguay (collection and concentration of ox bile)
Opening of the Des Moines plant in the USA (collection and concentration of pig bile)
Acquisition of RIAZ in Italy (collection and concentration of ox bile and pig bile)
Opening of Raichem (a 50% Joint Venture started in India)
Raichem becomes a fully owned subsidiary
Advent International acquires ICE Group
ICE Group was established in 1949 by husband-and-wife team Dr Walter and Ida Bartoli. From our humble origins in Northern Italy, we have grown organically and through acquisitions into the company we are today.
We have a vertically integrated model from sourcing to pharma grade production.
Europe, US, Latin America, South
Africa, India, Australia
Italy, New Zealand, India
As well as being the number-one player in the manufacture of UDCA, we also produce a comprehensive range of bile acid derivatives as well as other products we have developed.
Production plants, Italy
Production plant, New Zealand
Bile extraction plant
and Cholic Acid
Production plant, India
Custom Carbohydrate Synthesis & Manufacture, UK
Processing plant, Piacenza, Italy
Processing plants in, Texas & Iowa, USA
Bile extraction plants, Agentina, Uruguay & Paraguay